ロード中...
Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway
BACKGROUND: Epirubicin is a first-line chemotherapeutic drug for the clinical treatment of diffuse large B cell lymphoma (DLBCL), but the overexpression of multidrug resistance (MDR) transporter proteins, especially P-glycoprotein (P-gp), renders epirubicin ineffective. Some studies reveal the poten...
保存先:
| 出版年: | Transl Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Neoplasia Press
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7527585/ https://ncbi.nlm.nih.gov/pubmed/33007707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100876 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|